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The synthesis of the Lycopodium alkaloids (–)-cermizine B, (+)-serratezomine E, and (+)-luciduline 
using phenylglycinol-derived tricyclic lactams as chiral scaffolds, is reported. The requisite lactams are 
prepared by a cyclocondensation reaction between (R)- or (S)-phenylglycinol and the substituted δ-keto 
ester 11, easily accessible from (R)-pulegone. The factors governing the stereoselectivity of these 
cyclocondensation reactions are discussed. Key steps of the synthesis from the stereochemical standpoint 
are the stereoselective elaboration of the allyl substituent to an (S)-2-(piperidyl)methyl moiety and the 







The decahydroquinoline (DHQ) ring system is a common structural feature present in a large number 
of biologically active natural products. Unlike most alkaloid types, DHQ-containing alkaloids occur not 
only in plant species (e.g., phlegmarine in Lycopodium and myrioxazine A in Myrioneuron)1 but also in 
other terrestrial (e.g., pumiliotoxin C and gephyrotoxin 287C in amphibians and arthropods)2 and 








































Figure 1. Representative plant, amphibian and marine decahydroquinoline alkaloids. 
 
In particular, Lycopodium alkaloids can be grouped in four main structural classes, namely, 
lycopodine, lycodine, fawcettimine, and phlegmarine (also called the miscellaneous class), each one 
named after their most representative member. The phlegmarine-type alkaloids are characterized by a 
cis- or trans-decahydroquinoline ring system with a 7(R)-methyl substituent and a (2-piperidyl)methyl-
derived appendage at C-5 with both possible relative stereochemistries (Figure 2). In some members, 
the piperidine ring is oxidized to a nitrone or a pyridine, and in a few cases the DHQ 3- and 5-positions 
are connected by an oxidized two-carbon unit. Phlegmarine is believed to be the key intermediate in the 














































Figure 2. Representative phlegmarine-type Lycopodium alkaloids. 
 
As a consequence of their widespread distribution and different biogenetic origins, DHQ-containing 
alkaloids are structurally diverse in their substitution pattern and stereochemistry, which has stimulated 
the development of general methodologies and unified synthetic strategies for the stereoselective 
synthesis of substituted DHQ derivatives.4 In this context, in previous work we have used tricyclic 
aminoalcohol-derived oxazoloquinolone lactams as multipurpose enantiopure scaffolds for 
diastereoselective transformations into a variety of diversely substituted cis-decahydroquinolines, 
including the DHQ alkaloids (–)-pumiliotoxin, C,5 (–)-lepadins A-C,6 (+)-lepadin D,6b (+)-myrioxacin 
A,7 and (+)-gephyrotoxin 287C8 (Scheme 1). 
 




From the stereochemical standpoint, crucial steps in our syntheses of pumiliotoxin C and lepadins 
were a stereoselective cyclocondensation reaction of (R)-phenylglycinol with a cyclohexenone-derived 
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δ-keto ester and the subsequent stereoselective hydrogenation of the resulting rigid cis-fused tricyclic 
lactams 16,9 (Scheme 2). The configuration of the bridgehead carbons in 1 results from the irreversible 
lactamization of the intermediate oxazolidine A (in equilibrium with other three diastereoisomeric 
oxazolidines via the corresponding dienamine), through a chair-like transition state in which the ester 
chain avoids repulsive interactions with the R (A1,2 strain) and C6H5 substituents. Trans-fused lactams 
cannot be formed due to steric constraints. In turn, the hydrogenation of the C–C double bond of 
unsaturated lactams 1 takes place stereoselectively from the most accessible face to give lactams 2, with 
a 4a-H/5-H trans relative configuration (when R ≠ H; DHQ numbering). 
 
Scheme 2. Stereoselective Access to Phenylglycinol-Derived Oxazoloquinolone Tricyclic Lactams 
 
 
Results and Discussion 
We report herein our studies on the enantioselective synthesis of phlegmarine-type Lycopodium 
alkaloids using phenylglycinol-derived tricyclic lactams as chiral scaffolds. Only a limited number of 
enantioselective synthesis of these alkaloids have been reported to date.10-12 In a first approach, we 
envisaged unsaturated lactam 1a as a suitable starting material, because its allylic oxidation should 
afford an enone, from which the substituents at the DHQ C-5 and C-7 positions could be incorporated in 
a stereocontrolled manner. In the event, treatment of 1a with SeO213 afforded allylic alcohol 3 as a 
single stereoisomer,14 which was further oxidized under Dess–Martin conditions to give enone 4 in high 
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overall yield. To test the feasibility of conjugate addition reactions for the introduction of the DHQ C-5 
substituent and easily analyze their stereochemical outcome, in a model experiment enone 4 was 
allowed to react with n-BuLi in the presence of CuI. When the reaction was carried out in the usual THF 
or Et2O solvents, a nearly equimolecular mixture (determined by NMR) of 5 and its C-5 epimer was 
obtained (70-75% yield).15 However, surprisingly, the conjugate addition proceeded smoothly in 
CH2Cl2 to afford ketone 5 in 83% yield as a single diastereoisomer with a 4a-H/5-H trans relationship 
(Scheme 3). The configuration of 5 was unambiguously established after reduction of the ketone 
carbonyl. The resulting tricyclic lactam 2c was identical to that previously obtained9 by catalytic 
hydrogenation of unsaturated lactam 1c. The observed diastereoselectivity in the above conjugate 
addition reaction, involving a nucleophilic attack from the most hindered face of the enone, can be 
rationalized by considering that, in the absence of ethereal solvents, the oxazolidine oxygen coordinates 
with the nucleophilic species, thus directing the delivery of the nucleophile syn with respect to this 
oxygen. 
 
Scheme 3. The Decahydroquinoline C-5 Stereocenter. Model Studies 
 
These results prompted us to investigate an alternative way of generating the DHQ C-5 stereocenter, 
by conjugate reduction of enone 6. However, SeO2-promoted allylic oxidation of unsaturated lactam 1c 
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took place at the exocyclic methylene carbon instead of the endocyclic DHQ C-7 position to give ketone 
7c in excellent yield (Scheme 4). A similar oxidation from 1b gave aldehyde 7b in nearly quantitative 
yield. Steric factors probably account for the regioselectivity of the oxidation. Aldehyde 7b was 
efficiently converted in two steps to the silyl derivative 8, the TIPS analog of the intermediate 1d in our 
synthesis of lepadins.6  
 
Scheme 4. Regioselective Exocyclic Allylic Oxidation 
 
The desired regioselective endocyclic allylic oxidation of unsaturated lactam 1c was accomplished, 
although in moderate yield, by manganese(III) acetate-catalyzed oxidation using TBHP as the 
cooxidant.16 A subsequent methylcopper(I)-catalyzed conjugate reduction of the resulting enone 6 by 
DIBALH in the presence of HMPA17 afforded in good yield and complete facial selectivity the same 
tricyclic ketone 5 previously obtained by conjugate addition of a butyl residue. This result makes 
evident that the conjugate additions of hydride and butyl occur with opposite facial selectivity, both 
leading to the same trans 4a-H/5-H (DHQ numbering) relative stereochemistry, which had also been 
obtained by hydrogenation of the unsaturated lactams 1 resulting from the cyclocondensation reaction 
(Scheme 2). 
Although the above approach would allow the stepwise preparation of tricyclic lactams bearing 
substituents at the DHQ C-5 and C-7 positions, en route to phlegmarine-type alkaloids, at this point we 
turned our attention to an alternative, more efficient approach based on the direct generation of such 
disubstituted lactams using appropriately substituted cyclohexanone-derived δ-keto esters in the 
reaction with (R)- or (S)-phenylglycinol. These keto esters would be accessible by a conjugate addition 
to enone 9, which already incorporates the methyl substituent with the (R) absolute stereochemistry 






















































Enone 9 was prepared in four steps on a multigram scale (~70% overall yield) following literature 
procedures18 from (R)-pulegone, a commercially available compound of the chiral pool.19 Unfortunately, 
attempts to directly introduce a (2-pyridyl)methyl substituent by conjugate addition of a metalated 2-
picoline to enone 9 under a variety of experimental conditions20 were unsuccessful and the desired 
adduct 10 was not detected. To circumvent this problem, we decided to perform the conjugate addition 
of an allyl group, which would be subsequently elaborated to the (2-piperidyl)methyl moiety present in 
most phlegmarine-type alkaloids. The 1,4-addition was satisfactorily accomplished in nearly 
quantitative yield by an InCl3-catalyzed Sakurai reaction21 of enone 9 with allyltrimethylsilane in the 
presence of TMSCl. The reaction was completely stereoselective due to the stereoelectronic control,22 
affording  3,5-trans cyclohexanone 11 as an inconsequential 1:1 mixture of C-2 epimers.  The 
subsequent acid-catalyzed cyclocondensation of 11 with (R)-phenylglycinol also took place with 
complete stereoselectivity, via oxazolidine B, leading to the anticipated tricyclic lactam 12a14 in 82% 
yield, in a process that involves the epimerization of the configurationally labile stereocenter to the 
ketone group.23 The DHQ 4a-, 5-, and 7-carbons in lactam 12a had the required configuration for the 
synthesis of (–)-cermizine B, an alkaloid isolated from the club moss of Lycopodium cernuum.24 To 
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complete the synthesis, it was only necessary to stereoselectively install the (S)-(2-piperidyl)methyl 
moiety by manipulating the allyl substituent and generate the cis fusion for the DHQ system by 
stereoselective cleavage of the oxazolidine ring.  
The S stereogenic center α to the amino group of the DHQ C-5 substituent was installed by reaction of 
N-sulfinyl imine 13 with allylmagnesium bromide,25 which led to sulfinamide 14 as a single 
stereoisomer in 96% yield. Compound 13 was prepared from lactam 12a by RuCl3/NaIO4-promoted26 
oxidative cleavage of the allyl group, followed by Ti(O-i-Pr)4-mediated condensation of the resulting 
aldehyde with (R)-(+)-tert-butanesulfinamide27 (Scheme 6).  
 




The six-membered heterocyclic ring of the DHQ C-5 side chain was assembled from sulfinamide 14 in 
the three steps: cleavage of the sulfinyl group by acidic methanolysis, acylation of the resulting primary 
homoallylic amine with acryloyl chloride to give diene 15 (67% overall yield), and a final ring-closing 
metathesis reaction (83% yield). After catalytic hydrogenation of the C–C double bond of 
dihydropyridone 16 and methylation of the resulting piperidone, treatment with LiAlH4-AlCl3 caused 
both the reduction of the piperidone and perhydroquinolone lactam carbonyls and the stereoselective 
reductive cleavage of the oxazolidine C–O bond to give cis-DHQ 17 in 57% overall yield. A final 
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debenzylation by catalytic hydrogenation afforded (–)-cermizine B, whose NMR spectroscopic data 
matched those reported for the natural product.24,28  
The above successful result prompted us to develop a similar sequence for the synthesis of (+)-
serratezomine E, a cis-DHQ alkaloid isolated from the club moss Lycopodium serratum var. serratum29 
bearing the same C-5 and C-7 absolute configuration as (–)-cermizine B, but with the opposite 
configuration at the ring fusion carbons. It was expected that using (S)-phenylglycinol instead of the R 
enantiomer in the reaction with δ-keto ester 11 would afford tricyclic lactam 18b, with the required 
stereochemistry. As observed in related cyclocondensations,5-9 lactamization would preferentially take 
place from an oxazolidine (D; R1=H, R2=C6H5) in which the ester group approaches the nitrogen atom 
avoiding the repulsive interactions of the methoxy group with the phenyl substituent. Such interactions 
would occur in the tetrahedral intermediate generated in the alternative cyclization from oxazolidine C 
(R1=H, R2=C6H5). However, unexpectedly, in sharp contrast with the result of the cyclocondensation 
with (R)-phenylglycinol (Scheme 5 and Table 1, entry 1), the reaction of 11 with (S)-phenylglycinol was 
not stereoselective, affording (78% yield) a nearly equimolecular mixture of the expected lactam 18b 
and its diastereoisomer 18a (entry 2).30 To gain insight into the factors governing the stereoselectivity of 
the above cyclocondensation reactions, we studied the reaction of 11 with 2-aminoethanol, which lacks 
the phenyl substituent of the amino alcohol moiety, as well as other cyclocondensations using δ-keto 
esters 19 and 20 (mixtures of C-2 diastereoisomers), related to 11 but lacking one of the substituents at 










Table 1. Cyclocondensation Reactions 
 
entry amino alcohol R1 R2 δ-keto ester R3 R4 products a/b ratio  yield (%) 
1 (R)-Phenylglycinol   C6H5 H 11 CH3 CH2CH=CH2 12 1:0  82 




11 CH3 CH2CH=CH2 18 55:45 
 
78 
3 2-Aminoethanol H H 11 CH3 CH2CH=CH2 21 85:15  81 
4 (R)-Phenylglycinol   C6H5 H 19 CH3 H 22 1:0  76 
5 (S)-Phenylglycinol H 
C6H
5 
19 CH3 H 23 85:15 
 
83 
6 (R)-Phenylglycinol   C6H5 H 20 H CH3 24 1:1  68 








The reaction of 11 with 2-aminoethanol afforded an 85:15 mixture of lactams 21a and 21b (entry 3). 
Taking into account that lactamization of both possible oxazolidine precursors C and D (R1 = R2 = H) 
involves a chair-like transition state with one axial substituent (R4 or R3) on the cyclohexane ring, the 
preferential lactamization from oxazolidine C (R1 = R2 = H) in the absence of the phenyl substituent can 
be rationalized by considering that D suffers from additional repulsive gauche interactions between the 
equatorial allyl group and the propionate chain. Similar gauche interactions would explain the 
stereochemical outcome of the above cyclocondensation leading to lactams 18a and 18b. 
In the same way, the stereochemical outcome of the cyclocondensations of keto esters 19 and 20 with 
(R)- and (S)-phenylglycinol (table 1, entries 4-7) can be accounted for by analyzing in each case the 
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repulsive interactions during the irreversible lactamization of the intermediate equilibrating 
oxazolidines C and D: i) 1,3-diaxial interactions between the phenyl ring and the methoxy group; ii) 
axial substituents on the cyclohexane ring; and iii) gauche interactions between the equatorial R4 
substituent and the propionate chain. The existence or not of these interactions determines the 
stereoconvergent generation of tricyclic lactams 22a and 25b in the reactions of keto ester 19 with (R)-
phenylglycinol (entry 4) and keto ester 20 with (S)-phenylglycinol (entry 7), respectively; it also 
explains why the alternative cyclizations of 19 with (S)-phenylglycinol and 20 with (R)-phenylglycinol, 
leading to lactams 23 and 24, respectively, were less (a/b ratio 85:15; entry 5) or even not 
stereoselective (1:1 ratio; entry 6). 
Following our synthetic plan, lactam 18b was converted to (+)-serratezomine E as outlined in Scheme 
7. The synthetic sequence parallels the one previously developed for the synthesis of (–)-cermizine B, 
and proceeds via aldehyde 26, N-sulfinyl imine 27, sulfinamide 28, diene 29, dihydropyridone 30, and 
cis-DHQ 31. The piperidine nitrogen was protected as an N-Boc derivative to allow the selective 
acetylation of the DHQ nitrogen after the reductive removal of the phenylethanol moiety by 
hydrogenolysis. A final deprotection with TFA gave (+)-serratezomine E. The NMR data of our 
synthetic (+)-serratezomine E were coincident with those reported in the literature,10f while the specific 
rotation {[α]D = +6.1 (c 0.62, CHCl3)} was in good agreement with the value reported {[α]D = + 9.0 (c 









Scheme 7. Enantioselective Synthesis of (+)-Serratezomine E 
 
Taking into account that luciduline32 and nankakurines A and B33 (Figure 2) possess the same 
configuration at the C-4a, C-5, C-7, and C-8a DHQ stereocenters as serratezomine E, tricyclic lactam 
18b was also envisaged as a synthetic precursor of these more complex Lycopodium alkaloids. The 
additional bridged six-membered ring would be assembled taking advantage of the allyl substituent, 
which would be converted to an acetate chain, able to undergo a base-catalyzed cyclization with the 
position of the lactam carbonyl. The stereoselective removal of the chiral inductor, with simultaneous 
N-Boc protection, was accomplished from aldehyde 26 by the usual alane reduction / hydrogenolysis 
procedure to give the cis-DHQ-5-ethanol derivative 32 in 91% yield. A subsequent treatment with 
ruthenium tetroxide brought about both the reoxidation of the N-Boc-DHQ to the corresponding N-acyl 
lactam34 and the oxidation of the alcohol functionality to an acid, which was then converted to ester 33 
as shown in Scheme 8. The synthesis of (+)-luciduline was completed by cyclization of lactam ester 33 
with lithium isopropylcyclohexylamide, followed by LiAlH4 reduction of the resulting luciduline lactam 
3435 to give dihydroluciduline and a final Jones oxidation.11a Our synthetic luciduline showed NMR data 
and a specific rotation coincident with those reported11 for the natural product. Given that luciduline had 
previously been converted into nankakurines in the racemic series,36 the above synthesis also constitutes 









Phenylglycinol-derived tricyclic oxazoloquinolone lactams have proven to be multipurpose scaffolds 
for the enantioselective synthesis of structurally diverse DHQ-containing alkaloids. The results reported 
in this paper demonstrate that these lactams can be successfully used to assemble phlegmarine-type 
Lycopodium alkaloids, such as (–)-cermizine B, (+)-serratezomine E, and (+)-luciduline. Key 
stereoselective steps of the synthesis are the elaboration of the (S)-(2-piperidyl)methyl moiety from the 
allyl substituent and the generation of the cis-DHQ ring fusion by reductive opening of the oxazolidine 
ring.  
The chiral lactam scaffolds bearing the required DHQ C-5 and C-7 substituents and stereochemistry 
are more efficiently prepared by a straightforward cyclocondensation reaction between (R)- or (S)-
phenylglycinol and an appropriately substituted δ-keto ester 11, easily accessible from the chiral pool, 
than by a stepwise stereoselective introduction of the DHQ substituents on unsubstituted unsaturated 
tricyclic lactams. The factors governing the stereoselectivity of these and related cyclocondensation 
reactions have been rationalized, which will allow the design of related stereocontrolled 







quinoline (3): SeO2 (1.08 g, 9.76 mmol) was added to a stirring solution of lactam 1a (610 mg, 2.27 
mmol) in anhydrous dioxane (76 mL) at room temperature. The resulting suspension was heated at 
reflux for 24 h. The solvent was evaporated, and the residue was taken up in EtOAc. The organic 
solution was washed with water, dried, and concentrated. Flash chromatography (2:8 hexane–EtOAc) 
afforded alcohol 3 (505 mg, 78 %) as a white solid: [α]23D ‒ 26.8 (c 1.2, CHCl3); 1H-NMR (CDCl3, 400 
MHz, COSY, g-HSQC) δ (ppm): 1.58-1.68 (m, 2H, H-7, OH), 1.99 (dd, J = 4.8, 14.8 Hz, 1H, H-11), 
2.02-2.06 (m, 1H, H-7), 2.26 (dd, J = 1.6, 14.8 Hz, 1H, H-11), 2.33-2.36 (m, 1H, H-7a), 2.46-2.53 (m, 
1H, H-6), 2.68 (dd, J = 4.0, 6.0 Hz, 1H, H-6), 4.07-4.12 (m, 2H, H-2, H-10), 4.56 (t, J = 8.8 Hz, 1H, H-
2), 5.54 (t, J = 8.4 Hz, 1H, H-3), 5.83 (dd, J = 4.8, 9.6 Hz, 1H, H-9), 5.97 (dd, J = 4.8, 10 Hz, 1H, H-8), 
7.19 (d, J = 8.0 Hz, 2H, H-Ar), 7.24-7.28 (m, 1H, H-Ar), 7.32-7.36 (m, 2H, H-Ar); 13C-NMR (75.4 
MHz, CDCl3) δ (ppm): 24.7 (C-7), 31.1 (C-6), 34.2 (C-11), 40.5 (C-7a), 58.5 (C-3), 64.9 (C-10), 69.3 
(C-2), 94.2 (C-11a), 125.3 (2CH-Ar), 127.3 (CH-Ar), 128.3 (C-9) 128.6 (2CH-Ar), 129.1 (C-8), 139.8 
(C-Ar), 169.3 (NCO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C17H19NO3H 286.1438; Found 
286.1438.  
(3R,7aS,11aS)-5,10-Dioxo-3-phenyl-2,3,5,6,7,7a,10,11-octahydrooxazolo[2,3-j]quinoline (4): Dess-
Martin periodinane (1.97 g, 4.65 mmol) was added to a stirring solution of alcohol 3 (500 mg) in 
anhydrous CH2Cl2 (186 mL). The resulting suspension was stirred overnight at room temperature. 
Saturated aqueous NaHCO3 (60 mL) and saturated aqueous Na2S2O3 (60 mL) were added, and the 
mixture was stirred for 45 minutes. The layers were separated, and the aqueous solution was extracted 
with CH2Cl2. The combined organic extracts were dried and concentrated. Flash chromatography (3:7 
hexane–EtOAc) afforded enone 4 (343 mg, 85%) as a white-yellow residue: [α]23D ‒ 119 (c 1.0, CHCl3);  
1H-NMR (400 MHz, CDCl3, COSY, g-HSQC) δ (ppm): 1.82-1.97 (m, 1H, H-7), 2.18-2.27 (m, 1H, H-
7), 2.52-2.66 (m, 2H, H-7a, H-11), 2.72-2.89 (m, 3H, H-6, H-11), 3.98 (t, J = 8.2 Hz, 1H, H-2), 4.53 (t, 
J = 8.2 Hz, 1H, H-2), 5.46 (t, J = 8.2 Hz, 1H, H-3), 6.09 (d, J = 10.2 Hz, 1H, H-9), 6.95 (dd, J = 5.6, 
10.2Hz, 1H, H-8), 7.16 (d, J = 7.4 Hz, 2H, H-Ar), 7.26 (t, J = 7.4 Hz, 1H, H-Ar), 7.34 (t, J = 7.4 Hz, 
2H, H-Ar); 13C-NMR (75.4 MHz, CDCl3) δ (ppm): 23.7 (C-7), 31.0 (C-6), 41.6 (C-7a), 43.9 (C-11), 
58.9 (C-3), 69.6 (C-2), 94.9 (C-11a), 125.3 (2CH-Ar), 127.6 (CH-Ar), 128.3 (C-9) 128.8 (2CH-Ar), 
139.1 (Cq-Ar), 148.0 (C-8), 168.6 (NCO), 194.8 (C=O); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C17H17NO3H 284.1281; Found 284.1291. 
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(3R,7aS,8R,11aS)-8-Butyl-5,10-dioxo-3-phenylperhydrooxazolo[2,3-j]quinoline (5): Method A. n-
BuLi (560 µL, 2.5 M in hexane, 1.41 mmol) was added dropwise under argon to a suspension of CuI 
(135 mg, 0.71 mmol) in anhydrous Et2O (3.0 mL) at ‒20 ºC. After 30 minutes, the solvent was 
evaporated under a stream of argon. The resulting residue was dissolved in anhydrous CH2Cl2 (5 mL), 
and the mixture was stirred for 10 min at ‒20 ºC. Enone 4 (40 mg, 0.14 mmol) in anhydrous CH2Cl2 
(1.0 mL) was added dropwise at –78 ºC. The mixture was stirred at ‒78 ºC for 30 minutes and at ‒30 ºC 
for 3 h. Saturated aqueous NH4Cl was added, the phases were separated, and the aqueous phase was 
extracted with CH2Cl2. The combined organic extracts were dried and concentrated. Flash 
chromatography (3:7 hexane−EtOAc) afforded compound 5 (40 mg, 83%) as a yellowish oil: [α]23D ‒ 
80.1 (c 0.19, CHCl3); 1H-NMR (400 MHz, CDCl3, COSY, g-HSQC) δ: 0.91 (t, J = 6.8 Hz, 3H, CH3), 
1.25-1.37 (m, 4H, H-2’, H-3’), 1.39-1.49 (m, 1H, H-1’), 1.57-1.66 (m, 1H, H-1’), 1.77-1.83 (m, 1H, H-
8), 1.85-1.92 (m, 1H, H-7a), 1.93-2.01 (m, 1H, H-7), 2.03-2.11 (m, 1H, H-7), 2.42 (dd, J = 4.8, 16.0,  
Hz, 2H, H-9), 2.54 (ddd, J = 4.0, 10.8, 18.0 Hz, 1H, H-6), 2.64 (brs, 2H, H-11), 2.73 (dd, J = 4.0, 5.6 
Hz, 1H, H-6), 3.94 (dd, J = 7.6, 8.8 Hz, 1H, H-2), 4.52 (t, J = 8.8 Hz, 1H, H-2), 5.41 (t, J = 8.2 Hz, 1H, 
H-3), 7.12 (d, J = 7.4 Hz, 2H, H-Ar), 7.24 (t, J = 7.4 Hz, 1H, H-Ar), 7.32 (t, J = 7.4 Hz, 2H, H-Ar); 13C-
NMR (100.6 MHz, CDCl3) δ: 14.0 (CH3), 22.6 (C-3’), 25.3 (C-7), 29.4 (C-2’), 31.3 (C-6), 34.8 (C-1’), 
38.2 (C-8), 41.8 (C-9), 43.7 (C-7a), 45.3 (C-11), 58.0 (C-3), 69.5 (C-2), 96.2 (C-11a), 125.3 (2CH-Ar), 
127.4 (CH-Ar), 128.7 (2CH-Ar), 139.4 (Cq-Ar), 169.4 (C-5), 207.1 (C-10); HRMS (ESI-TOF) m/z: [M 
+ H]+ Calcd for C21H27NO3H 342.2064;  Found 342.2063. 
Method B. MeLi (74 µL, 1.6 M in Et2O, 0.12 mmol) was added to a suspension of CuI (23 mg, 0.12 
mmol) in anhydrous THF (300 µL) at 0 ºC. The resulting yellow/brown suspension was cooled to ‒50 
ºC, and HMPA (60 µL, 20 % v/v) and DIBALH (240 µL, 1 M in hexane, 0.24 mmol) were sequentially 
added. After 30 minutes, the mixture was cooled to ‒65 ºC, and compound 6 (see below; 20 mg, 0.06 
mmol) in anhydrous THF (300 µL) was added dropwise. The mixture was allowed to warm to ‒50 ºC, 
and stirring was continued for 2 h. 1 M aqueous HCl was added, the phases were separated, and the 
aqueous phase was extracted with CH2Cl2. The combined organic extracts were filtered over Celite®, 
and the solvent was evaporated. Flash chromatography (4:6 hexane−EtOAc) afforded compound 5 (15 
mg, 75%) as a yellowish oil. 
(3R,7aS,8R,11aS)-8-Butyl-5-oxo-3-phenylperhydrooxazolo[2,3-j]quinoline (2c): 1st step. BF3·Et2O 
(5 µL, 0.04 mmol) was added to a solution of ketone 5 (44 mg, 0.13 mmol) and 1,3-propanedithiol (20 
µL, 0.194 mmol) in anhydrous CH2Cl2 (2.0 mL), and the mixture was stirred at room temperature for 16 
h. 2 M aqueous NaOH was added, the phases were separated, and the aqueous phase was extracted with 




2nd step. Ni-Raney (200 mg) was added to a solution of the above crude in absolute EtOH (2.3 mL), and 
the slurry suspension was heated to reflux for 23 h. After cooling to room temperature, 5% aqueous HCl 
was added, and the resulting suspension was filtered over Celite®. The solvent was evaporated, and the 
residue was re-dissolved in 10% aqueous NaOH and extracted with CH2Cl2. The combined organic 
extracts were dried and concentrated. Flash chromatography (6:4, hexane–EtOAc) afforded lactam 2c 
(24 mg, 55% overall yield) as a white residue: [α]23D − 77.1 (c 1.1, MeOH); 1H-NMR (400 MHz, 
CDCl3, COSY, g-HSQC) δ (ppm): 0.91 (t, J = 6.8 Hz, 3H, H-4’), 1.24-1.84 (m, 15H), 2.11-2.23 (m, 
1H), 2.47 (ddd, J = 18.5, 11.0, 7.2 Hz, 1H, H-6), 2.64 (dd, J = 18.5, 7.2 Hz, 1H, H-6), 3.83 (t, J = 8.4 
Hz, 1H, H-2), 4.51 (t, J = 8.4 Hz, 1H, H-2), 5.30 (t, J = 8.4 Hz, 1H, H-3), 7.15-7.33 (m, 5H, H-Ar); 13C-
NMR (100.6 MHz, CDCl3) δ (ppm): 14.2 (CH3), 18.0 (C-10), 22.8 (C-7), 24.2 (C-11), 24.8 (C-7), 30.5 
(C-9), 30.6 (CH2), 31.3 (C-6), 32.9 (CH2), 39.9 (C-8), 43.7 (C-7a), 58.0 (C-3), 69.6 (C-2), 95.5 (C-11a), 
125.4 (2CH-Ar), 127.0 (CH-Ar), 128.5 (2CH-Ar), 140.3 (C-i), 169.5 (NCO). 
(3R,7aS,11aS)-8-Butyl-5,10-dioxo-3-phenyl-2,3,5,6,7,7a,10,11-octahydrooxazolo[2,3-j]quinolone 
(6): Mn(OAc)3 (8.3 mg, 0.03 mmol) was added under argon to a stirring solution of lactam 1c (50 mg, 
0.15 mmol) and TBHP (140 µL, 5.5 M in decane, 0.77 mmol) in  EtOAc (9 mL) containing 3Ǻ 
molecular sieves (180 mg). The mixture was stirred at 50 ºC for 40 h and filtered over Celite®. After 
washing with EtOAc, the solvent was evaporated. Flash chromatography (6:4 hexane–EtOAc) afforded 
enone 6 (21 mg, 40%) as a colorless oil: [α]23D ‒ 97.1 (c 1.05, CHCl3); 1H-NMR (400 MHz, CDCl3, 
COSY, g-HSQC) δ: 0.95 (t, J = 7.4 Hz, 3H, CH3), 1.34-1.43 (m, 2H, H-3’), 1.45-1.66 (m, 2H, H-2’), 
1.79-1.95 (m, 1H, H-1’), 2.21-2.40 (m, 3H, H-7, H-1’), 2.45 (dd, J = 3.6, 13.2 Hz, 1H, H-7a), 2.56-2.65 
(m, 1H, H-6), 2.72-2.86 (m, 3H, H-6, H-11), 3.94 (t, J = 8.4 Hz, 1H, H-2), 4.50 (t, J = 8.4 Hz, 1H, H-2), 
5.41 (t, J = 8.4 Hz, 1H, H-3), 5.95 (s, 1H, H-9), 7.18 (d, J = 7.4 Hz, 2H, H-Ar), 7.26 (t, J = 7.4 Hz, 1H, 
H-Ar), 7.34 (t, J = 7.4 Hz, 2H, H-Ar); 13C-NMR (100.6 MHz, CDCl3) δ: 13.8 (CH3), 22.3 (C-3’), 23.7 
(C-1’), 29.1 (C-2’), 31.1 (C-6), 35.2 (C-7), 43.1 (C-11), 45.4 (C-7a), 59.1 (C-3), 69.7 (C-2), 95.2 (C-
11a), 124.5 (C-9), 125.4 (2CH-Ar), 127.6 (CH-Ar), 128.8 (2CH-Ar), 139.1 (Cq-Ar), 164.3 (C-8), 168.5 
(NCO), 194.7 (C=O); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C21H25NO3H 340.1907; Found 
340.1917. 
(3R,7aS,11aS)-8-Formyl-5-oxo-3-phenyl-2,3,5,6,7,7a,10,11-octahydrooxazolo[2,3-j]quinoline (7b): 
Operating as in the preparation of compound 3, from lactam 1b (100 mg, 0.35 mmol) and SeO2 (169 
mg, 1.52 mmol) in anhydrous dioxane (12 mL), aldehyde 7b (105 mg, 99%) was obtained as a dark 
orange foam after filtration over a short pad of silica: mp: 175-177 ºC; [α]23D ‒ 128.7 (c 0.875, CHCl3); 
1H-NMR (400 MHz CDCl3, COSY, g-HSQC) δ (ppm): 1.59-1.62 (m, 1H, H-7), 1.80-1.92 (m, 1H, H-
11), 1.94-2.04 (m, 1H, H-11), 2.25-2.36 (m, 1H, H-7), 2.39-2.47 (m, 2H, H-10), 2.55-2.59 (m, 2H, H-6), 
2.69-2.75 (m, 1H, H-7a), 3.93 (t, J = 8.3 Hz, 1H, H-2), 4.56 (t, J = 8.3 Hz, 1H, H-2), 5.51 (t, J = 8.3 Hz, 
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1H, H-3), 6.84 (t, J = 3.6 Hz, 1H, H-9), 7.18 (dd, J = 7.2, 3.6 Hz, 2H, H-Ar), 7.26 (t,  J = 7.2 Hz, 1H, H-
Ar), 7.34 (t, J = 7.4 Hz, 2H, H-Ar), 9.48 (s, 1H, CHO); 13C-NMR (100.6 MHz, CDCl3) δ (ppm): 24.5 
(C-10), 25.0 (C-7), 26.4 (C-11), 31.1 (C-6), 37.9 (C-7a), 58.4 (C-3), 69.6 (C-2), 93.2 (C-11a), 125.3 
(2CH-Ar.), 127.3 (CH-Ar.), 128.7 (2CH-Ar.), 140.1 (Cq-Ar.), 141.5 (C-8), 149.7 (C-9), 169.5 (C-5), 
192.7 (CHO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C18H19NO3H 298.1438; Found 298.1432. 
(3R,7aS,11aS)-5-Oxo-8-(4-oxobutyl)-3-phenyl-2,3,5,6,7,7a,10,11-octahydrooxazolo[2,3-j]quinoline 
(7c): Operating as in the preparation of compound 3, from lactam 1c (50 mg, 0.15 mmol) and SeO2 (74 
mg, 0.66 mmol) in anhydrous dioxane (5 mL), ketone 7c (47 mg, 89%) was obtained after flash 
chromatography (7:4 hexane–EtOAc) as a colorless oil: [α]23D ‒ 181.8 (c 1.1, CHCl3); IR (NaCl): 1663 
cm-1; 1H-NMR (400 MHz, CDCl3, COSY, g-HSQC ) δ (ppm): 0.93 (t, J = 7.4 Hz, 3H, CH3), 1.47-1.58 
(m, 1H, H-7), 1.59-1.74 (m, 2H, H-3’), 1.75-1.88 (m, 1H, H-11), 1.90-1.99 (m, 1H, H-11), 2.19-2.27 
(m, 1H, H-7), 2.34 (brs, 2H, H-10), 2.57-2.69 (m, 4H, H-6, H-2’), 2.83 (d, J = 11.6 Hz, 1H, H-7a), 3.91 
(t, J = 8.2 Hz, 1H, H-2), 4.54 (t, J = 8.2 Hz, 1H, H-2), 5.49 (t, J = 8.2 Hz, 1H, H-3), 6.93 (t, J = 3.4 Hz, 
1H, H-9), 7.18 (d, J = 7.4 Hz, 2H, H-Ar), 7.25 (d, J = 5.2 Hz, 1H, Ar), 7.33 (t, J = 7.4 Hz, 2H, Ar); 13C-
NMR (100.6 MHz, CDCl3) δ (ppm):13.8 (CH3), 18.0 (C-3’), 24.1 (C-10), 25.7 (C-11), 25.8 (C-7), 31.3 
(C-6), 38.8 (C-7a), 39.1 (C-2’), 58.5 (C-3), 69.5 (C-2), 93.7 (C-11a), 125.3 (2CH-Ar), 127.2 (CH-Ar), 
128.6 (2CH-Ar), 138.6 (C-9) 139.4 (Cq-Ar), 140.2 (C-8), 169.7 (NCO), 199.7 (C=O); HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C21H25NO3H 340.1907; Found 340.1911. 
(3R,7aS,11aS)-8-(Hydroxymethyl)-5-oxo-3-phenyl-2,3,5,6,7,7a,10,11-octahydrooxazolo[2,3-
j]quinoline: NaBH4 (13 mg, 0.34 mmol) was added in portions to a stirring solution of aldehyde 7b 
(100 mg, 0.34 mmol) in absolute EtOH (3 mL) at 0 ºC, and the mixture was stirred at room temperature 
for 45 minutes. Then, water was added, the ethanol was removed under reduced pressure, and the 
aqueous phase was extracted with EtOAc. The combined organic extracts were dried and concentrated 
to afford the title alcohol (90 mg, 90%) as a sticky yellowish solid: [α]23D  ‒ 101.2 (c 1.0, CHCl3); IR 
(NaCl): 3041, 1655, 1629 cm-1; 1H-NMR (CDCl3, 400 MHz, COSY, g-HSQC) δ (ppm): 1.61-1.86 (m, 
2H, H-11), 1.90 (dd, J = 14.4, 5.8 Hz, 1H, H-7), 2.03-2.23 (m, 2H, H-10), 2.25-2.36 (m, 1H, H-7), 2.37 
(brs, 1H, H-7a) 2.52 (ddd, J = 11.4, 7.6, 4.2 Hz, 1H, H-6), 2.68 (dd, J = 18.4, 6.4 Hz, 1H, H-6), 3.91 (t, 
J = 8.4 Hz, 1H, H-2), 4.06-4.18 (m, 2H, CH2OH)  4.57 (t, J = 8.4 Hz, 1H, H-2), 5.47 (t, J = 8.4 Hz, 1H, 
H-3), 5.75 (brs, 1H, H-9), 7.15-7.37 (m, 5H, H-Ar); 13C-NMR (CDCl3, 100.6 MHz) δ (ppm): 22.9 (C-
10), 25.1 (C-7), 26.1 (C-11), 31.3 (C-6), 40.9 (C-11), 58.5 (C-3), 65.3 (CH2OH), 69.5 (C-2), 94.2 (C-
11a), 123.4 (C-9), 125.3 (2CH-Ar), 127.2 (CH-Ar), 128.6 (2CH-Ar), 137.4 (C-8), 140.2 (Cq-Ar), 169.6 




octahydrooxazolo[2,3-j]quinoline (8): TIPSCl (300 µL, 1.4 mmol) was added to a stirring solution of 
the above alcohol (280 mg, 0.94 mmol) and imidazole (96 mg, 1.4 mmol) in anhydrous DMF (2 mL), 
and the mixture was stirred at room temperature for 17 h. Brine was added, and the resulting mixture 
was stirred for 20 minutes and extracted with CH2Cl2. The combined organic extracts were washed with 
brine, dried, and concentrated. Flash chromatography (from hexane to 75:25 hexane–EtOAc) afforded 
compound 8 (360 mg, 84%) as a sticky white residue: IR (NaCl): 1645 (NCO) cm-1; [α]23D  ‒ 37.2 (c 
0.48 CHCl3); 1H-NMR (CDCl3, 400 MHz) δ (ppm): 1.05-1.15 [m, 21H, Si(iPr)3] 1.65-1.92 (m, 3H), 
2.05-2.20 (m, 2H), 2.25-2.37 (m, 2H), 2.45-2.54 (m, 1H), 2.68 (dd, J = 18.4, 6.4 Hz, 1H), 3.90 (t, J = 
8.0 Hz, 1H), 4.25 [brs, 2H, CH2OSi(iPr)3],  4.56 (t, J = 8.0 Hz, 1H), 5.46 (t, J = 8.0 Hz, 1H), 5.72 (brs, 
1H), 7.18-7.35 (m, 5H, H-Ar); 13C-NMR (CDCl3, 100.6 MHz) δ (ppm): 12.0 (CH); 18.0 (CH3); 22.8 
(CH2), 25.4 (CH2), 26.3 (CH2), 31.4 (CH2), 41.2 (CH2), 58.5 (CH), 65.8 [CH2OSi(iPr)3], 69.5 (CH2) 
93.3 (Cq), 120.8 (CH), 125.3 (CH-Ar), 125.4 (CH-Ar), 127.1 (CH-Ar), 128.5 (CH-Ar), 128.6 (CH-Ar), 
136.9 (Cq), 140.3 (Cq-Ar), 169.7 (Cq); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C27H41NO3SiH 
456.2928; Found 456.2933. 
Methyl (2R,4R)-2-allyl-4-methyl-6-oxocyclohexanepropionate (11): A solution of compound 918 (4.0 
g, 20.4 mmol) in anhydrous CH2Cl2 (8.0 mL), TMSCl (13 mL, 102 mmol), and AllylTMS (3.57 mL, 
22.44 mmol) were added sequentially to a solution of InCl3 (451 mg, 2.04 mmol) in anhydrous CH2Cl2 
(68 mL), and the resulting mixture was stirred at room temperature for 4 h. Saturated aqueous NaHCO3 
was added, and the aqueous phase was separated and extracted with CH2Cl2. The combined organic 
extracts were dried and concentrated. Flash chromatography (96:4 hexane–EtOAc), afforded keto ester 
11 (4.8 g, 99%; 1:1 mixture of C-2 epimers) as a colorless oil: 1H-NMR (400 MHz, CDCl3, COSY, g-
HSQC) δ (ppm): 0.93 and 0.96 (d, J = 6.4 Hz, 3H, CH3), 1.38-1.45 (m, 1H), 1.47-1.54 (m, 1H), 1.59-
1.67 (m, 1H), 1.83-1.90 (m, 1H), 1.92-1.98 (m, 1H), 2.00-2.16 (m, 4H), 2.18-2.24 (m, 1H), 2.28 (t, J = 
7.6 Hz, 1H), 2.32-2.39 (m, 1H), 2.50-2.54 (m, 1H), 3.63 (s, 3H), 4.93-5.03 (m, 2H), 5.58-5.74 (m, 1H); 
13C-NMR (100.6 MHz, CDCl3) δ (ppm):  21.0 and 22.2 (CH3), 21.8 and 24.7 (CH2), 29.3 and 29.5 
(CH), 31.7 and 31.9 (CH2), 34.3 (CH2), 36.6 and 39.1 (CH2), 39.1 and 40.4 (CH), 47.2 and 50.2 (CH2), 
51.4 and 51.5 (OCH3), 52.7  and 53.6 (CH), 116.4 and 117.0 (CH2), 135.7 and 136.2 (CH), 173.6 and 
173.8 (COO), 211.6 and 213.4 (CO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C14H22O3H 239.1642; 
Found 239.1639. 
(3S,7aS,8R,10R,11aS)-8-Allyl-10-methyl-5-oxo-3-phenylperhydrooxazolo[2,3-j]quinoline (18a) and 
(3S,7aR,8R,10R,11aR)-8-allyl-10-methyl-5-oxo-3-phenylperhydrooxazolo[2,3-j]quinoline (18b): 
(S)-Phenylglycinol (1.7 g, 12.6 mmol) was added to a solution of keto ester 11 (2.0 g, 8.39 mmol) and 
AcOH (720 µL, 12.6 mmol) in benzene (67 mL). The mixture was heated at reflux with azeotropic 
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elimination of water by a Dean-Stark system. After 24 h, the mixture was cooled to room temperature 
and concentrated, and the resulting oil was taken up in EtOAc. The organic solution was washed with 
saturated aqueous NaHCO3, 1 M aqueous HCl and brine, dried, and concentrated. Flash 
chromatography (from 9:1 to 7:3 hexane–EtOAc) afforded pure lactams 18a (1.15 mg, 43%) and 18b 
(971 mg, 35%) as yellowish residues. 18b (higher Rf): [α]23D + 79.0 (c 2.0, CHCl3); IR (NaCl): 1655, 
1398 cm-1; 1H-NMR (CDCl3, 400 MHz, COSY, g-HSQC) δ (ppm): 1.13 (d, J = 7.6 Hz, 3H, CH3), 1.32-
1.41 (m, 1H, H-9), 1.50 (dt, J = 5.2, 13.2 Hz, 1H, H-9), 1.79-1.89 (m, 5H, H-7, H-7a, H-11), 2.11-2.23 
(m, 3H,-10, H-1’), 2.30-2.35 (m, 1H, H-8), 2.43-2.53 (m, 1H, H-6), 2.66-2.74 (m, 1H, H-6), 3.92 (t, J = 
8.6 Hz, 1H, H-2), 4.35 (t, J = 8.6 Hz, 1H, H-2), 5.07-5.14 (m, 2H, CH=CH2), 5.37 (t, J = 8.6 Hz, 1H, H-
3), 5.78-5.90 (m, 1H, CH=CH2), 7.23 (d, J = 7.4 Hz, 2H, H-Ar), 7.28-7.33 (m, 1H, H-Ar), 7.38 (t, J = 
7.4 Hz, 2H, H-Ar); 13C-NMR (CDCl3, 100.6 MHz) δ (ppm): 16.0 (C-11), 19.4 (CH3), 27.4 (C-10), 30.6 
(C-6), 30.7 (C-8), 31.4 (C-9), 34.2 (C-7), 37.7 (C-1’), 43.2 (C-7a), 58.8 (C-3), 69.5 (C-2), 95.9 (C-11a), 
116.1 (C=CH2), 125.3 (2CH-Ar), 127.0 (CH-Ar), 128.5 (2CH-Ar), 136.6 (CH=C), 140.1 (Cq-Ar), 169.2 
(C-5); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C21H27NO2H 326.2115; Found 326.2122. 18a (lower 
Rf): [α]23D ‒ 44.5 (c 2.0, CHCl3); IR (NaCl): 1656, 1435 cm-1; 1H-NMR (CDCl3, 400 MHz, COSY, g-
HSQC) δ (ppm): 0.91 (d, J = 6.0 Hz, 3H, CH3), 1.15 (t, J = 13.8 Hz, 1H, H-11), 1.33 (dt, J = 4.8, 8.4 
Hz, 1H, H-9), 1.49-1.53 (m, 1H, H-9), 1.71-1.81 (m, 2H, H-7, H-8), 1.87-1.96 (m, 2H, H-10. H-11), 
1.97-2.03 (m, 1H, H-7), 2.05-2.12 (m, 1H, H-7a), 2.22-2.30 (m, 1H, H-1’), 2.32-2.40 (m, 2H, H-6, H-
1’), 2.48-2.58 (m, 1H, H-1’), 3.86 (dd, J = 1.8, 7.2 Hz, 1H, H-2), 4.35 (dd, J = 1.8, 7.2 Hz, 1H, H-2), 
4.86 (dd, J = 1.8, 7.2 Hz, 1H, H-3), 5.04-5.10 (m, 2H, CH=CH2), 5.80 (dddd, J = 7.2, 10.2, 14.4, 17.2 
Hz 1H, CH=CH2), 7.15-7.20 (m, 1H, H-Ar), 7.22-7.30 (m, 4H, H-Ar); 13C-NMR (CDCl3, 100.6 MHz) δ 
(ppm): 21.9 (CH3), 24.2 (C-7), 24.6 (C-10), 30.3 (C-1’), 32.8 (C-9), 38.1 (C-11), 38.3 (C-6), 39.4 (C-8), 
41.0 (C-7a), 58.6 (C-3), 70.8 (C-2), 95.3 (C-11a), 116.1 (C=CH2), 126.2 (2CH-Ar), 127.2 (CH-Ar), 
128.4 (2CH-Ar), 138.2 (CH=C), 142.1 (Cq-Ar), 167.2 (NCO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd 
for C21H27NO2H 326.2115; Found 326.2119. 
(3S,7aR,8S,10R,11aR)-10-Methyl-5-oxo-8-(2-oxoethyl)-3-phenylperhydrooxazolo[2,3-j]quinoline 
(26): RuCl3.nH2O in H2O (3.9 mL, 0.14 mmol, 0.035 M stock solution) was added to a solution of 
lactam 18b (1.27 g, 3.9 mmol) in MeCN (23 mL) under vigorous stirring. NaIO4 (1.67 g, 7.8 mmol) was 
then added in portions over 5 min, and the stirring was continued for 1 h 20 min. Saturated aqueous 
Na2S2O3 was added, the resulting mixture was diluted with EtOAc, the phases were separated, and the 
aqueous solution was extracted with EtOAc. The combined organic extracts were dried and 
concentrated. Flash chromatography (4:6 hexane–EtOAc) afforded aldehyde 26 (970 mg, 76%) as a 
white foam: [α]23D + 121.1 (c 1.1, CHCl3); IR (NaCl): 2931, 2707 and 1721, 1611 cm-1; 1H-NMR 
(CDCl3, 400 MHz, COSY, g-HSQC) δ (ppm): 1.11 (d, J = 7.6 Hz, 3H, CH3), 1.28-1.32 (m, 1H, H-9), 
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1.51 (ddd, J = 21.2, 6.8, 5.6 Hz, 1H, H-9), 1.72-1.86 (m, 5H, H-7, H-7a, H-11), 2.03-2.08 (m, 1H, H-
10), 2.34-2.47 (m, 3H, H-6, H-1’), 2.66 (dd, J = 18, 6.4 Hz, 1H, H-6), 2.86-2.94 (m, 1H, H-8), 3.87 (dd, 
J = 8.4, 8.8 Hz, 1H, H-2), 4.53 (t, J = 8.8 Hz, 1H, H-2), 5.31 (t, J = 8.2 Hz, 1H, H-3), 7.16-7.18 (m, 2H, 
H-Ar), 7.22-7.26 (m, 1H, H-Ar), 7.30-7.34 (m, 2H, H-Ar), 9.76 (s, 1H, CHO); 13C-NMR (CDCl3, 100.6 
MHz) δ (ppm): 16.5 (C-7), 19.2 (CH3), 25.9 (C-8), 27.2 (C-10), 30.4 (C-6), 31.3 (C-9), 33.7 (C-11), 
43.5 (C-7a), 47.2 (C-1’), 58.8 (C-3), 69.4 (C-2), 95.4 (C-11a), 125.2 (2CH-Ar), 127.0 (CH-Ar), 128.4 
(2CH-Ar), 140.0 (Cq-Ar), 168.8 (NCO), 201.2 (CHO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C20H25NO3H 328.1907; Found 328.1916. 
 (3S,7aR,8S,10R,11aR)-8-[(R,E)-2-(tert-Butylsulfinylimino)ethyl]-10-methyl-5-oxo-3-
phenylperhydrooxazolo[2,3-j]quinoline (27): (R)-(+)-tert-butanesulfinamide (63 mg, 0.55 mmol) was 
added to a solution of 26 (131 mg, 0.4 mmol) and Ti(iOPr)4 (270 µL, 0.88 mmol) in anhydrous THF (2 
mL) under vigorous stirring. After 7 h at room temperature, brine was added under vigorous stirring, 
and the mixture was diluted with EtOAc. The suspension was filtered over Celite® and washed with 
EtOAc. The filtrate was dried and concentrated. Flash chromatography (4:6 hexane–EtOAc) afforded 
compound 27 (143 mg, 83%) as a white foam: [α]23D  ‒ 98.35 (c 0.85, CHCl3); IR (NaCl): 1654, 1622, 
1082 cm-1; 1H-NMR (CDCl3, 400 MHz, COSY, g-HSQC)) δ (ppm): 1.08 (d, J = 7.2 Hz, 3H, CH3), 1.21 
[s, 9H, C(CH3)3], 1.36-1.40 (m, 1H, H-9), 1.54 (ddd, J = 21.2, 6.6, 5.4 Hz, 1H, H-9), 1.78-1.89 (m, 5H, 
H-7, H-7a, H11), 2.02-2.11 (m, 1H, H-10), 2.34-2.43 (m, 1H, H-6), 2.51-2.55 (m, 2H, H-1’), 2.64-2.70 
(m, 1H, H-6), 2.76-2.85 (m, 1H, H-8), 3.86 (dd, J = 8.8, 8.0 Hz, 1H, H-2), 4.51 (t, J = 8.8 Hz, 1H, H-2), 
5.30 (t, J = 8.4 Hz, 1H, H-3), 7.16-7.18 (m, 2H, H-Ar), 7.22-7.26 (m, 1H, H-Ar), 7.32 (t, J = 7.4 Hz, 2H, 
H-Ar), 8.09 (t, J = 4.8 Hz, 1H, H-2’); 13C-NMR (CDCl3, 100.6 MHz) δ (ppm): 16.5 (C-7), 19.5 (CH3), 
22.4 [C(CH3)3], 27.4 (C-10), 28.7 (C-8), 30.5 (C-6), 31.4 (C-9), 34.1 (C-11), 39.9 (C-1’), 43.9 (C-7a), 
56.6 [C(CH3)3], 58.9 (C-3), 69.6 (C-2), 95.5 (C-11a), 125.4 (2CH-Ar), 127.2 (CH-Ar), 128.6 (2CH-Ar), 
140.0 (Cq-Ar), 168.2 (NCO), 168.9 (HC=NSO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C24H34N2O3SH 431.2363; Found 431.2365. 
(3S,7aR,8S,10R,11aR)-8-{(S)-2-[(R)-tert-Butylsulfinylamino]pent-4-enyl}-10-methyl-5-oxo-3-
phenylperhydrooxazolo[2,3-j]quinoline (28): Allylmagnesium bromide (4.64 mL, 1 M in Et2O, 4.64 
mmol) was slowly added to a stirring solution of N-sulfinyl imine 27 (1.0 g, 2.32 mmol) in anhydrous 
CH2Cl2 (23 mL) at 0 ºC. After 2 h, saturated aqueous NH4Cl was added, and the resulting mixture was 
diluted with EtOAc. The phases were separated, and the aqueous solution was extracted with EtOAc. 
The combined organic extracts were dried and concentrated. Flash chromatography (from CH2Cl2 to 
9.85:0.15 CH2Cl2–MeOH) afforded sulfinamide 28 (965 mg, 88%) as a yellow foam: [α]23D + 46.3 (c 
0.88, CHCl3);  IR (NaCl): 3427, 1645, 1056 cm-1; 1H-NMR (CDCl3, 400 MHz, COSY, g-HSQC) δ 
(ppm): 1.04 (d, J = 7.2 Hz, 3H, CH3), 1.22-1.26 [m, 10H, C(CH3)3, H-9], 1.36-1.53 (m, 3H, H-9, H-1’), 
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1.69-1.84 (m, 5H, H-7, H-7a, H-11), 2.00-2.06 (m, 1H, H-10), 2.35-2.47 (m, 4H, H-6, H-3’, H-8), 2.65 
(dd, J =6.2, 18.2 Hz, 1H, H-6), 3.22 (d, J = 7.6 Hz, 1H, NH), 3.29-3.38 (m, 1H, H-2’), 3.83 (dd, J =8.0, 
8.8 Hz, 1H, H-2), 4.43 (t, J = 8.6 Hz, 1H, H-2), 5.15-5.19 (m, 2H, H-5’), 5.29 (t, J = 8.2 Hz, 1H, H-3), 
5.73-5.84 (m, 1H, H-4’), 7.15-7.17 (m, 2H, H-Ar), 7.21-7.24 (m, 1H, H-Ar), 7.29-7.33 (m, 2H, H-Ar); 
13C-NMR (CDCl3, 100.6 MHz) δ (ppm): 16.2 (C-7), 19.4 (CH3), 22.7 [C(CH3)3], 26.9 (C-8), 27.4 (C-
10), 30.6 (C-6), 32.0 (C-9), 34.2 (C-11), 38.4 (C-1’), 41.0 (C-3’), 42.7 (C-7a), 52.9 (C-2’), 56.0 
[C(CH3)3], 58.8 (C-3), 69.4 (C-2), 95.7 (C-11a), 119.4 (C-5’), 125.4 (2CH-Ar), 127.1 (CH-Ar), 128.5 
(2CH-Ar), 133.6 (C-4’), 140.0 (Cq-Ar), 169.1 (NCO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C27H40N2O3SH 473.2832; Found 473.2841. 
(3S,7aR,8S,10R,11aR)-8-[(S)-2-(Acryloylamino)pent-4-enyl]-10-methyl-5-oxo-3-
phenylperhydrooxazolo[2,3-j]quinoline (29): 1st step. 1 M HCl in Et2O (4.14 mL, 4.14 mmol) was 
slowly added to a stirred solution of sulfinamide 28 (738 mg, 1.66 mmol) in anhydrous MeOH (2 mL). 
After 1 h, the solvent was evaporated, and the resulting amine HCl salt was used without further 
purification in the next step. 
2nd step. Acryloyl chloride (2.0 mL, 26.5 mmol) was slowly added to a biphasic mixture of the above 
crude amine hydrochloride in H2O–CH2Cl2 (16.5 mL, 1:1) and Et3N (3.70 mL, 26.5 mmol) at 0 ºC. The 
mixture was stirred for 20 h at room temperature. Then, the mixture was diluted with CHCl3, and the 
layers were separated. The aqueous solution was extracted with CHCl3. The combined organic extracts 
were washed with brine, dried, and concentrated. Flash chromatography (from 4:6 to 3:7 hexane–
EtOAc) afforded acrylamide 29 (445 mg, 64%) as a white foam: [α]23D + 83.55 (c 1.03, CHCl3); IR 
(NaCl): 2924, 1655, 1403 cm-1; 1H-NMR (CDCl3, 400 MHz, COSY, g-HSQC) δ (ppm): 1.04 (d, J = 7.6 
Hz, 3H, CH3), 1.31-1.33 (m, 1H, H-9), 1.42-1.52 (m, 3H, H-9, H-1’), 1.69-1.80 (m, 5H, H-7, H-7a, 
H11), 2.00-2.05 (m, 1H, H-10), 2.16-2.44 (m, 4H, H-6, H-8, H-3’), 2.58-2.64 (m, 1H, H-6), 3.82 (dd, J 
= 8.0, 8.4 Hz, 1H, H-2), 4.07-4.16 (m, 1H, H-2’), 4.46  (t, J = 8.8 Hz, 1H, H-2), 5.06-5.10 (m, 2H, H-
5’), 5.25-5.29 (m, 1H, H-3), 5.58 (dd, J = 1.6, 10.0 Hz, 1H, CH2=CHCO), 5.71-5.81 (m, 2H, H-4’, NH), 
6.06 (dd, J = 10.4, 16.8 Hz, 1H, CH2=CHCO), 6.24 (dd, J = 1.6, 16.8 Hz, 1H, CH2=CHCO), 7.14-7.16 
(m, 2H, H-Ar), 7.20-7.23 (m, 1H, H-Ar), 7.28-7.31 (m, 2H, H-Ar); 13C-NMR (CDCl3, 100.6 MHz) δ 
(ppm): 16.3 (C-7), 19.4 (CH3), 27.3 (C-10), 27.6 (C-8), 30.7 (C-6), 31.5 (C-9), 34.2 (C-11), 37.5 (C-1’), 
38.7 (C-3’), 43.4 (C-7a), 46.3 (C-2’), 58.8 (C-3), 69.4 (C-2), 95.6 (C-11a), 118.2 (C-5’), 125.3 (2CH-
Ar), 126.1 (CH2=CHCO), 127.0 (CH-Ar), 128.5 (2CH-Ar), 131.0 (CH2=CHCO), 134.0 (C-4’), 140.1 
(Cq-Ar), 165.0 (NCO), 169.0 (NCO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C26H34N2O3H 
423.2642; Found 423.2640. 
(3S,7aR,8S,10R,11aR)-10-Methyl-8-{[(S)-6-oxo-2-piperidyl]methyl}-5-oxo-3-phenyl 
perhydrooxazolo[2,3-j]quinoline (30): Second generation Grubbs’ catalyst (33 mg, 0.04 mmol) was 
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added to a stirring solution of acrylamide 29 (330 mg, 0.78 mmol) in degassed anhydrous CH2Cl2 (26 
mL). The resulting brown solution was stirred at reflux temperature for 4 h. After cooling to room 
temperature, the mixture was stirred for an additional hour exposed to air. The solvent was evaporated 
under reduced pressure. Flash chromatography (from EtOAc to 95:5 EtOAc–MeOH) afforded 
dihydropyridone 30 (267 mg, 86%) as a brown foam: [α]23D  + 61.3 (c 0.95, CHCl3); IR (NaCl): 3229, 
1676, 1651 cm-1; 1H-NMR (CDCl3, 400 MHz, COSY, g-HSQC) δ (ppm): 1.08 (d, J = 7.6 Hz, 3H, CH3), 
1.26-1.29 (m, 1H, H-9), 1.47-1.63 (m, 3H, H-9, H-1’), 1.72-1.87 (m, 5H, H-7, H-7a, H-11), 2.01-2.21 
(m, 3H, H-10, H-7’), 2.31-2.46 (m, 2H, H-6, H-8), 2.67 (dd, J = 6.8, 18.4 Hz, 1H, H-6), 3.63-3.71 (m, 
1H, H-2’), 3.85 (t, J = 8.6 Hz, 1H, H-2), 4.51 (t, J = 8.6 Hz, 1H, H-2), 5.30 (t, J = 8.4 Hz, 1H, H-3), 
5.92-6.06 (m, 2H, H-5’, NH), 6.59-6.64 (m, 1H, H-6’), 7.16-7.18 (m, 2H, H-Ar), 7.23-7.27 (m, 1H, H-
Ar), 7.31-7.35 (m, 2H, H-Ar); 13C-NMR (CDCl3, 100.6 MHz) δ (ppm): 16.3 (C-7), 19.4 (CH3), 27.0 (C-
8), 27.1 (C-10), 30.1 (C-7’), 30.5 (C-6), 31.6 (C-9), 34.0 (C-11), 38.7 (C-1’), 43.5 (C-7a), 48.2 (C-2’), 
58.9 (C-3), 69.5 (C-2), 95.5 (C-11a), 124.5 (C-5’), 125.3 (2CH-Ar), 127.1 (CH-Ar), 128.5 (2CH-Ar), 
140.0 (Cq-Ar), 140.3 (C-6’), 166.3 (NCO), 168.8 (NCO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C24H30N2O3H 395.2329; Found 395.2332. 
(3S,7aR,8S,10R,11aR)-10-Methyl-8-{[(S)-6-oxo-2-piperidyl]methyl}-5-oxo-3-phenyl 
perhydrooxazolo[2,3-j]quinoline: A solution of dihydropyridone 30 (262 mg, 0.66 mmol) in MeOH 
(5.8 mL) containing Pd/C (52 mg, 10% Pd) was stirred under hydrogen at room temperature for 15 h. 
The catalyst was removed by filtration, and the solvent was evaporated affording the title piperidone 
(252 mg, 96%) as a colorless oil: [α]23D  + 87.2 (c 1.11, CHCl3); IR (NaCl): 2930, 1655 cm-1; 1H-NMR 
(CDCl3, 400 MHz, COSY, g-HSQC) δ (ppm): 1.07 (d, J = 7.2 Hz, 3H, CH3), 1.23-1.27 (m, 1H, H-9), 
1.34-1.53 (m, 4H, H-9, H-1’, H-6’), 1.65-1.84 (m, 5H, H-7, H-9, H-7’, H-7a, H-11), 1.89-1.97 (m, 3H, 
H-10, H-6’, H-7’), 2.03-2.08 (m, 1H, H-10), 2.25-2.46 (m, 4H, H-6, H-8, H-5’), 2.66 (dd, J = 6.2, 18.6 
Hz, 1H, H-6), 3.40-3.48 (m, 1H, H-2’), 3.85 (t, J = 8.6 Hz, 1H, H-2), 4.51 (t, J = 8.8 Hz, 1H, H-2), 5.30 
(t, J = 8.2 Hz, 1H, H-3), 6.26 (s, 1H, NH), 7.16-7.18 (m, 2H, H-Ar), 7.22-7.26 (m, 1H, H-Ar), 7.29-7.34 
(m, 2H, H-Ar); 13C-NMR (CDCl3, 100.6 MHz) δ (ppm): 16.3 (C-7), 19.4 (CH3), 19.6 (C-7’), 26.8 (C-8), 
27.1 (C-10), 28.6 (C-6’), 30.5 (C-6), 31.2 (C-5’), 31.6 (C-9), 34.0 (C-11), 40.2 (C-1’), 43.5 (C-7a), 50.1 
(C-2’), 58.8 (C-3), 69.4 (C-2), 95.4 (C-11a), 125.2 (2CH-Ar), 127.0 (CH-Ar), 128.4 (2CH-Ar), 140.0 
(Cq-Ar), 168.8 (NCO), 172.2 (NCO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C24H32N2O3H 
397.2486; Found 397.2478. 
(4aR,5S,7R,8aS)-1-[(S)-2-Hydroxy-1-phenylethyl]-7-methyl-5-{[(S)-2-piperidyl] 
methyl}decahydroquinoline: LiAlH4 (3.57 mL, 1 M in THF, 3.57 mmol) was added to a stirring 
solution of AlCl3 (147 mg, 1.10 mmol) in anhydrous THF (10 mL) at 0 ºC. After 10 minutes, the 
mixture was allowed to warm to room temperature and stirred for an additional 30 minutes. The mixture 
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was cooled to ‒78 ºC, and after 10 minutes a solution of the above piperidone (218 mg, 0.55 mmol) in 
anhydrous THF (3.0 mL) was added. The stirring was continued at –78 °C for 90 min and at room 
temperature for 2 h. Water was slowly added, and the resulting mixture was diluted with EtOAc. The 
phases were separated, and the aqueous solution was extracted with EtOAc. The combined organic 
extracts were dried and concentrated. Flash chromatography (from CH2Cl2 to 8:2 CH2Cl2–MeOH) 
afforded the title cis-DHQ (157 mg, 77%) as a colorless oil: [α]23D ‒ 0.83 (c 0.68 , CHCl3); IR (NaCl): 
3331, 2928 cm-1; 1H-NMR (CDCl3, 400 MHz, COSY, g-HSQC) δ (ppm): 0.47 (d, J = 7.2 Hz, 3H, CH3), 
0.97-1.05 (m, 2H), 1.08-1.14 (m, 1H), 1.18-1.36 (m, 7H), 1.37-1.57 (m, 2H), 1.59-1.71 (m, 4H), 1.75-
1.84 (m, 3H), 1.88-1.96 (m, 1H, H-7), 2.47-2.54 (m, 1H), 2.58-2.67 (m, 2H), 2.87-2.94 (m, 2H), 3.09-
3.12 (m, 1H), 3.21 (brs, 1H, OH), 3.63 (t, J = 4.6, 1H, H-1’), 3.73 (dd, J = 4.2, 10.6 Hz, 1H, H-2’), 3.88 
(dd, J = 5.2, 10.8 Hz, 1H, H-2’), 7.27-7.38 (m, 5H, CH-Ar); 13C-NMR (CDCl3, 100.6 MHz) δ (ppm): 
17.4 (CH2), 17.8 (CH3), 23.3 (C-3), 24.4 (CH2), 25.6 (CH2), 27.3 (C-7), 29.7 (CH2), 30.4 (C-5), 32.3 
(CH2), 33.0 (CH2), 40.1 (CH), 40.2 (CH2), 43.8 (CH2), 46.6 (CH2), 51.8 (CH), 53.7 (CH), 63.1 (C-2’), 
67.2 (C-1’), 127.5 (CH-Ar), 128.3 (2CH-Ar), 128.6 (2CH-Ar), 140.1 (Cq-Ar); HRMS (ESI-TOF) m/z: 
[M + H]+ Calcd for C24H38N2OH 371.3057; Found 371.3045. 
(4aR,5S,7R,8aS)-5-{[(S)-1-tert-(Butoxycarbonyl)-2-piperidyl]methyl}-1-[(S)-2-hydroxy-1-
phenylethyl]-7-methyldecahydroquinoline (31): Di-tert-butyl dicarbonate (86 mg, 0.39 mmol) was 
added to a stirring solution of the above cis-DHQ (132 mg, 0.36 mmol) in anhydrous CH2Cl2 (6 mL) at 
room temperature. After 24 h, the solvent was evaporated under reduced pressure. Flash 
chromatography (from CH2Cl2 to 8:2 CH2Cl2–MeOH) of the residue afforded carbamate 31 (140 mg, 
83%) as a brown oil: [α]23D  + 2.16  (c 1.375, CHCl3); IR (NaCl): 3288, 1686 cm-1; 1H-NMR (CDCl3, 
400 MHz) δ (ppm): 0.43 (brs, 3H, CH3), 1.21-1.30 (m, 7H), 1.31-1.41 (m, 4H), 1.47 [s, 9H, C(CH3)3], 
1.51-1.57 (m, 3H), 1.63-1.78 (m, 1H), 1.80-1.87 (m, 1H), 1.95 (brs, 1H), 2.05-2.43 (m, 5H), 2.66-2.74 
(m, 2H), 3.10 (brs, 1H), 3.64-3.94 (m, 3H), 4.19 (brs, 1H), 7.28-7.34 (m, 3H, CH-Ar), 7.42-7.44 (m, 2H, 
CH-Ar);  13C-NMR (CDCl3, 100.6 MHz) δ (ppm): 16.8 (CH2), 17.5 (CH3), 18.9 (CH2), 23.4, 25.6 
(CH2), 27.2 (CH), 28.4 (CH2), 28.5 [OC(CH3)3], 29.2, 29.6 (CH2), 30.9 (CH2), 31.0 (CH), 32.5 (CH2), 
33.0 (CH2), 38.7(CH2), 44.7 (CH2), 47.8 (CH2), 63.2 (CH2), 67.2 (CH), 79.1, [OC(CH3)3], 128.1 (CH-
Ar), 128.5 (2CH-Ar), 129.0 (2CH-Ar), 154.9 (NCO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C29H46N2O3H 471.3581; Found 471.3576.                                                                                                                       
(4aR,5S,7R,8aS)-1-Acetyl-5-{[(S)-1-tert-(butoxycarbonyl)-2-piperidyl]methyl}-7-
methyldecahydroquinoline: 1st step. A suspension of 31 (120 mg, 0.26 mmol) in MeOH (4.6 mL) 
containing Pd(OH)2 (48 mg) was stirred under hydrogen at room temperature for 24 h. The catalyst was 
then removed by filtration over Celite® and washed with MeOH, and the solvent was evaporated to give 
crude N-unsubstituted DHQ. 
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2nd step. TEA (39 µL, 0.28 mmol) and acetyl chloride (18 µL, 0.26 mmol) were added to a stirring 
solution of the above residue in CH2Cl2 (0.5 mL) at 0 ⁰C, and the mixture was stirred for 15 h at room 
temperature. Then, saturated aqueous NaHCO3 was added, the phases were separated, and the aqueous 
solution was extracted with CH2Cl2. The combined organic extracts were dried and concentrated. Flash 
chromatography (from CH2Cl2 to 8:2 CH2Cl2–MeOH) afforded the title N-acetyl-DHQ  (76 mg, 76%) 
as a yellow oil: [α]23D  ‒ 6.22  (c 0.58, CHCl3); IR (NaCl): 1686, 1644 cm-1; 1H-NMR (CDCl3, 400 
MHz, COSY, g-HSQC) δ (ppm): 1.08 and 1.04 (d, J = 7.6, 7.2 Hz, 3H, CH3), 1.14-1.20 (m, 2H), 1.28-
1.40 (m, 4H), 1.44 and 1.45 [s, 9H, C(CH3)3], 1.47-1.58 (m, 5H), 1.62-1.79 (m, 4H), 1.88-1.94 (m, 1H), 
1.95-2.03 (m, 1H), 2.04 and 2.06 (s, 3H, COCH3), 2.08-2.17 (m, 2H), 2.60 (ddd, J = 3.2, 13.2, 14.4 Hz, 
0.5H, H-2), 2.74 (t, J = 12.2 Hz, 1H, H-4’), 3.11 (ddd, J = 2.8, 12.6 Hz, 0.5H, H-2), 3.55 (d, J = 14.0 
Hz, 0.5H, H-2), 3.87 (ddd, J = 2.6, 7.6, 8.8 Hz, 0.5H, H-8a), 3.97 (brs, 1H), 4.18-4.24 (m, 1H, H-4’), 
4.47 (dd, J = 2.8, 13.6 Hz, 0.5H, H-2), 4.86 (ddd, J = 4.8, 8.4, 9.2 Hz, 0.5H, H-8a); 13C-NMR (CDCl3, 
100.6 MHz) δ (ppm): 17.5 and 17.7 (C-4), 18.5 and 18.7 (CH3), 18.8 and 19.0 (CH2), 21.2 and 22.1 
(COCH3), 25.1 and 26.1 (C-3), 25.6 (CH2), 27.3 and 27.7 (C-7), 28.4 (C-8), 28.5 [C(CH3)3], 29.8 (CH2), 
30.7 (C-5), 32.0 and 32.4 (C-6), 32.9 and 33.1 (C-1’), 36.5 and 41.7 (C-2), 38.9 (C-4’), 38.9 and 39.3 
(C-4a), 46.3 and 52.1 (C-8a), 47.9 (C-2’), 79.2 [C(CH3)3], 154.9 (NCO), 168.5 and 168.9 (CO); HRMS 
(ESI-TOF) m/z: [M + H]+ Calcd for C23H40N2O3H 393.3112; Found 393.3100. 
(+)-Serratezomine E: TFA (41 µL, 0.535 mmol) was slowly added to a stirring solution of the above 
DHQ (21 mg, 0.0535 mmol) in anhydrous CH2Cl2 (535 µL) at room temperature. The mixture was 
stirred for 1 h, and the solvent was evaporated. Flash chromatography (KP-NH Biotage® SNAP 
cartridges, from CH2Cl2 to 8:2 CH2Cl2–MeOH) afforded (+)-serratezomine E (14.6 mg, 95%) as a 
colorless oil: [α]23D  + 6.10 (c 0.62, CHCl3) [Lit10f +9 (c 1, CHCl3)]; 1H-NMR (CDCl3, 400 MHz) δ 
(ppm): δ 1.06 and 1.08 (d, J = 7.2 Hz, 3H, CH3), 1.14- 1.25 (m, 4H), 1.28-1.46 (m, 6H), 1.51 (m, 1H), 
1.60-1.80 (m, 6H), 1.89-1.94 (m, 2H), 2.05 and 2.09 (s, 3H, COCH3), 2.11-2.15 (m, 1H), 2.39-2.50 (m, 
1H), 2.55 (t, J = 3.2 Hz, 0.5 H), 2.58-2.65 (m, 1H), 3.03-3.09 (m, 0.5H), 3.12 (td, J = 4.0, 13.2 Hz, 1H), 
3.55 (m, 0.5H), 3.91 (dt, J = 4.2, 12.4 Hz, 0.5H), 4.46 (dd, J = 4.0, 13.0 Hz, 0.5 H), 4.88 (dt, J = 4.4, 
13.2 Hz, 0.5H); 13C-NMR (CDCl3, 100.6 MHz) δ 17.5 and 17.6 (CH2), 18.5 and 18.7 (CH3), 21.3 and 
22.1 (COCH3), 24.7 and 24.8 (CH2), 25.0 and 26.0 (CH2), 26.4 and 26.5 (CH2), 27.3 and 27.7 (CH), 
28.5 and 30.0 (CH2), 29.5 and 29.8 (CH), 32.5 and 32.8 (CH2), 33.1 and 33.3 (CH2), 36.4 and 41.8 
(CH2), 38.5 and 39.5 (CH), 40.6 and 40.7 (CH2), 46.2 and  52.1 (CH), 47.0 and 47.1 (CH2), 53.4 (CH), 
168.6 and 169.1 (CO).  
(4aR,5S,7R,8aS)-1-(tert-Butoxycarbonyl)-5-(2-hydroxyethyl)-7-methyldecahydroquinoline (32): 
1st step. LiAlH4 (5.88 mL, 1 M in THF, 5.88 mmol) was added to a stirring solution of AlCl3 (2418 mg, 
1.84 mmol) in anhydrous THF (18 mL) at 0 ºC. After 30 minutes, the mixture was cooled to ‒78 ºC, and 
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after 10 minutes a solution of 26 (296 mg, 0.9 mmol) in anhydrous THF (3 mL) was added. The stirring 
was continued at –78 °C for 90 min and at room temperature for 3 h. Water was slowly added, and the 
resulting mixture was diluted with EtOAc. The phases were separated, and the aqueous solution was 
extracted with EtOAc. The combined organic extracts were dried and concentrated to give crude 
dialcohol. 
2nd step. A solution of the above residue and Boc2O (237 mg, 1.08 mmol) in MeOH (18 mL) containing 
Pd(OH)2 (115 mg) was stirred under hydrogen at room temperature for 24 h. The catalyst was removed 
by filtration over Celite®, and the filtrate was concentrated. Flash chromatography (85:15 hexane–
EtOAc) afforded cis-decahydroquinoline 32 (246 mg, 91%) as a colorless oil: [α]23D  + 15.7 (c 0.97, 
CHCl3); IR (NaCl): 3355, 1732 cm-1; 1H-NMR (CDCl3, 400 MHz, COSY, g-HSQC) δ (ppm):  1.03 and 
1.07 (d, J = 7.2 Hz, 3H, CH3), 1.14-1.24 (m, 2H), 1.28-1.35 (m, 2H), 1.38-1.42 (m, 2H), 1.42-1.47 [m, 
10H, C(CH3)3], 1.48-1.57 (m, 1H), 1.60-1.73 (m, 3H), 1.89-1.97 (m, 2H), 2.09-2.10 (m, 1H, H-7), 2.70-
2.84 (m, 1H, H-2), 3.60-3.69 (m, 2H, CH2OH), 3.82-3.86 (m, 0.5H, H-2), 3.90-3.93 (m, 0.5H, H-2), 
4.20 (dt, J = 4.2, 13.2 Hz, 0.5H, H-8a), 4.37 (m,  J = 4.4, 13.2 Hz, 0.5H, H-8a); 13C-NMR (CDCl3, 
100.6 MHz) δ (ppm): 17.3 and 17.4 (CH2), 18.3 and 18.7 (CH3), 25.2 and 25.6 (CH2), 27.5 and 27.7 (C-
7), 28.4 and 28.9 (CH2), 28.4 and 28.5 [OC(CH3)3], 30.3 and 30.4 (CH), 32.3 and 32.5 (CH2), 36.2 and 
36.3 (CH2), 38.4 and 39.4 (C-2), 39.0 and 39.2 (CH), 48.2 and 49.4 (CH), 60.7 and 60.9 (CH2OH), 79.0 
and 79.1 [OC(CH3)3], 154.7 and 155.1 (NCO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C17H31NO3H 298.2377; Found 298.2380. 
Methyl (4aR,5S,7R,8aS)-1,7-dimethyl-2-oxodecahydroquinolin-5-acetate (33): 1st step. 10% 
aqueous solution of NaIO4 (4.1 mL) and RuO2·nH2O (3 mg, 0.02 mmol) were added to a stirred solution 
of 32 (246 mg, 0.83 mmol) in EtOAc (1.6 mL). After 17 h, EtOAc (1.5 mL) was added, the organic 
layer was separated, and the aqueous phase was extracted with EtOAc. The combined organic extracts 
were filtered over Celite®, and the filtrate was dried and concentrated to give a crude lactam acid.  
2nd step. TFA (630 µL, 8.3 mmol) was slowly added to a stirring solution of the above acid in 
anhydrous CH2Cl2 (8.3 mL) at room temperature. After 1 h of stirring, the solvent was evaporated and 
the residue was taken up with anhydrous DMF (8.3 mL). NaH (99 mg, 4.13 mmol) was added to the 
solution, and the resulting suspension was stirred at room temperature for 1 h. Then, MeI (256 µL, 4.13 
mmol) was added, and the stirring was continued for 48 h. Saturated aqueous NH4Cl was added, the 
mixture was diluted with CH2Cl2, the layers were separated, and the aqueous phase was extracted with 
CH2Cl2. The combined organic extracts were washed with brine, dried, and concentrated. Flash 
chromatography (3:1 hexane–acetone) afforded 33 (121 mg, 58%) as a yellowish oil: [α]23D + 22.2 (c 
1.42, CHCl3); IR (NaCl): 1736, 1639 cm-1; 1H-NMR (CDCl3, 400 MHz, COSY, g-HSQC) δ (ppm): 1.04 
(d, J = 7.2 Hz, 3H, CH3), 1.23-1.28 (m, 1H), 1.41 (ddd, J = 5.0, 6.4, 21.6 Hz, 1H),  1.49-1.58 (m, 2H), 
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1.72-1.83 (m, 2H), 2.02-2.09 (m, 1H), 2.10-2.15 (m, 1H), 2.18-2.32 (m, 3H), 2.34-2.40 (m, 1H), 2.42-
2.48 (m, 1H), 2.89 (s, 3H, NCH3), 3.41 (dt, J = 4.6, 12.4 Hz, 1H,  H-8a), 3.66 (s, 3H, COCH3); 13C-
NMR (CDCl3, 100.6 MHz) δ (ppm): 15.4 (CH2), 18.4 (CH3), 27.2 (CH), 30.6 (CH), 31.1 (CH2), 31.9 
(CH2), 32.0 (CH2), 33.7 (NCH3), 37.4 (CH), 38.1 (CH2), 51.6 (COCH3), 56.8 (C-8a), 169.6 (NCO), 
172.8 (CO2Me); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C14H23NO3H 254.1751; Found 254.1753. 
(+)-Luciduline lactam (34): A solution of N-isopropylcyclohexylamine (190 µL, 1.15 mmol) in 
anhydrous THF (3.8 mL) was treated with n-BuLi (720 µL, 1.6 M in THF, 1.15 mmol) at –78 °C, and 
the mixture was stirred for 30 min at this temperature. The resulting solution was added dropwise under 
argon at –78 °C over 20 min to a solution of 33 (117 mg, 0.46 mmol) in anhydrous THF (23 mL). After 
stirring at this temperature for 2 h, the solution was poured into 1 M HCl at 0 °C, the layers were 
separated, and the aqueous phase was extracted with EtOAc. The combined organic extracts were 
washed with brine, dried, and concentrated. Flash chromatography (3:1 hexane–acetone) afforded 34 
(80 mg, 78%) as a colourless oil: [α]23D + 92. 8 (c 0.79, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ (ppm): 
0.96 (d, J = 6.8 Hz, 3H, CH3), 1.34-1.40 (m, 1H), 1.55-1.59 (m, 1H), 1.63-1.72 (m, 2H), 2.03-2.10 (m, 
2H), 2.23-2.28 (m, 2H), 2.30-2.41 (m, 2H), 2.62 (dd, J = 12.4, 14.4 Hz, 1H), 2.99 (s, 3H, NCH3), 3.32-
3.33 (m, 1H), 3.66-3.68 (m, 1H); 13C-NMR (CDCl3, 100.6 MHz) δ (ppm): 20.1 (CH), 21.8 (CH3), 30.4 
(NCH3), 31.3 (CH2), 33.0 (CH), 36.4 (CH), 38.1 (CH2), 38.9 (CH2), 42.7 (CH2), 55.8 (CH), 58.2 (CH), 
167.7 (NCO), 205.8 (CO). 
(+)-Luciduline: 1st step. LiAlH4 (1.25 mL, 1 M in THF, 5.88 mmol) was added to a stirring solution of 
34 (55 mg, 0.248 mmol) in anhydrous Et2O (15 mL) at 0 °C, and the mixture was stirred at reflux 
temperature for 1 h. After cooling, water was slowly added at 0 °C, and the resulting mixture was 
diluted with EtOAc. The phases were separated, and the aqueous phase was extracted with EtOAc. The 
combined organic extracts were dried and concentrated to give crude alcohol. 
2nd step. A solution of the above residue in acetone (1.6 mL) was added at room temperature to Jones 
reagent (2.5 mL) freshly prepared by dissolving CrO3 (700 mg) in water (5 mL), H2SO4 (1.2 mL), and 
acetone (100 mL). After 30 min, water was slowly added at 0 °C, and the resulting mixture was basified 
with 3 M aqueous NaOH. The aqueous solution was extracted with EtOAc, and the combined organic 
extracts were dried and concentrated. Flash chromatography (KP-NH Biotage® SNAP cartridges, from 
hexane to 8:2 hexane–AcOEt) afforded (+)-luciduline (37 mg, 72%) as an unstable light yellow oil: 
[α]23D + 86.0 (c 0.13, MeOH) [Lit.11a + 87 (c 2.05, MeOH); Lit.11b + 85.3 (c 0.15, MeOH); Lit.11c + 87.3 
(c 0.495, MeOH)]; 1H-NMR (CDCl3, 400 MHz) δ (ppm): 0.89 (d, J = 6.8 Hz, 3H, CH3), 0.95-1.02 (m, 
1H), 1.21-1.29 (m, 1H), 1.50-1.56 (m, 1H), 1.69 (br s, 1H), 1.81-1.90 (m, 2H), 1.91-2.01 (m, 1H), 2.02-
2.08 (m, 1H), 2.12-2.18 (m, 1H), 2.13 (s, 3H, NCH3), 2.23-2.25 (m, 1H), 2.27-2.37 (m, 2H), 2.39-2.43 
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